Effect of crosslinking with riboflavin and ultraviolet a (UVA) on the scleral tissue structure

Cover Page


Cite item

Abstract

Aim. To evaluate the effect of scleral crosslinking with riboflavin and ultraviolet A (UVA) on scleral tissue structure in vitro.

Material and methods. The study was performed on seven porcine cadaver eyes. Two parallel scleral strips were excised from each eyeball; one was subjected to the crosslinking procedure (instillation of 0.1% aqueous solution of riboflavin mononucleotide for 20 min followed by UV irradiation of 3 mW/cm2 for 30 min), and the other was used as control. Scleral structure was evaluated using light (Van Gieson’s stain) and electron microscopy. Special software was used to perform morphometric analysis of the microphotographs.

Results. As a result of crosslinking, the average packing density of collagen fibers increased by 8.2%, the intermediate space decreased by 5.2%, and the average diameter of collagen fibrils increased by 12%. There were no pathological changes in the scleral structures.

Conclusion. Obtained results confirm the efficacy of scleral crosslinking with riboflavin/UVA in forming additional crosslinks and the safety of the procedure for the scleral tissue.

Full Text

Myopia is one of the main causes of impaired vision, affecting nearly 1 million people worldwide [10, 11]. Myopia progression is observed in approximately half of these cases and still remains a challenge for ophthalmologists [6]. A number of authors believe that scleral crosslinking may become a new effective method for the treatment of progressive myopia, as this disease is associated with a decreased biomechanical strength of the sclera [7, 13, 16]. Crosslinking is the process of chemically joining two or more macromolecules, which generally results in strengthening of thematerial [1, 17]. For more than 10 years, the corneal crosslinking with riboflavin and ultraviolet A (UVA) has been successfully applied for the treatment of keratectasia. This method provides corneal tissue strengthening, thus preventing disease progression [2, 5]. Several studies have demonstrated significant improvements in biomechanical parameters of the sclera in response to photochemical crosslinking [3, 9, 14, 18]. However, very few studies have attempted to assess histological changes in the sclera that occur after the procedure [7, 8, 15]. We propose thatinvestigation of morphological changes in the sclera after photochemical crosslinking could provide valuable information on the safety of this procedure.

This study aimed to assess the impact of riboflavin/UVA crosslinking on the structure of the scleral tissue in an in vitro experiment.

Materials and methods

Preparation of scleral tissue samples. We used seven pig eyes (no later than 3 h after slaughtering). Biomaterial was shipped to the laboratory within 30–40 min after collection in a special thermocontainer (at +4 °C) and placed in a refrigerator. The total time of storage did not exceed 6 h.

The surrounding soft tissues were completely removed from the eyeballs. Using a scalpel and surgical scissors, two 4 mm × 10 mm scleral flaps were cut in each eyeball in the sagittal direction, starting 2 mm from the limbus. One of the two scleral samples of each eye underwent crosslinking (experimental group), and the second paired sample was left intact (control group).

Crosslinking procedure. Scleral samples from the experimental group were placed on a slide with the exterior surface facing upward, there was further application of 0.1% aqueous solution of riboflavin mononucleotide, and samples were incubated for 20 min. Samples were exposed to UVA (at a wavelength of 370 nm and power of 3 mW/cm2) using the ophthalmic device for ultraviolet (UV) crosslinking ‘UValink’ (Russia) for 30 min. Every 5 min, a fresh portion of photosensitizer was added to the samples.

Eight samples (from four eyeballs) were investigated using light microscopy and six (from three eyeballs) using electron microscopy.

Light microscopy. Scleral flaps were fixed in 10% neutral buffered formalin for 48 h. Then the samples were dehydrated in graded alcohols and embedded in paraffin wax. Afterward, histological sections of 5–7 μm thick were cut and stained using Van Gieson’s pichro-fuchsin. Visual analysis of the samples was performed using the light microscope Axiostar Plus (Carl Zeiss) at different magnifications. Morphometric measurements were made using a computerized medical video system that included microscope (Axiostar Plus, Carl Zeiss), digital camera (Jenoptik ProgRes C10),and personal computer Pentium-IV with the software “VideoTesT Morphology.” The software was used for automatic calculation of the size (in pixels) of variously stained scleral structures (collagen fibers, sclerocyte nuclei, and interstitial space). Outputs containing data on relative areas of sclera structures (in % of the total area) had particular practical value (Figure 1).

 

Fig. 1. Morphometric measurements of scleral histological sections photographs with the “VideoTesT Morphology” software

 

Electron microscopy. Specimens for electron microscopy were fixed in 2% glutaraldehyde in Millonig’s phosphate buffer (рН, 7.2–7.4) with postfixation in 1% osmium oxide in the same buffer. Specimens were dehydrated in graded alcohols and embedded in the Epon 812 according to a standard technique [4]. Semithin and ultrathin sections were prepared using an ultratome LKB-III 8800 (Sweden), then contrasted with 2% aqueous uranyl acetate and plumbum citrate according to Reynolds, and they examined and photographed with a transmission electronic microscope Jem-1011 (JEOL Ltd., Japan) at 5,000–20,000 magnification. Diameters of collagen fibrils were compared on the basis of photographic image analysis (at 10,000 magnification) using the Olympus iTEM software for electronograms (Figure 2).

 

Fig. 2. Collagen fibrils diameter measurement with the Olympus iTEM software

 

Results

Light microscopy of sclera samples allowed visualization of red collagen fibers and black sclerocyte nuclei in both experimental and control samples. We found no signs of pathological changes in the samples that underwent crosslinking (Figure 3).

 

Fig. 3. Histological section of scleral samples from experimental and control groups. Van Gieson staining, magnification ×100

 

We performed morphometric analysis of the images to compare relative areas of collagen fibers and the interstitial space in experimental and control groups. These parameters were used to assess the impact of crosslinking on the packing density of scleral tissue (Tables 1 and 2).

 

Table 1. Comparison of the relative area of collagen fibers (% of the total area) in the experimental and control groups

Таблица 1. Сравнение относительной площади (% от общей площади) коллагеновых волокон в опытной и контрольной группах

Eye

Experiment,%

Control, %

Increase in the relative area of collagen fibers in the experimental samples compared with control samples, %

1

66.63

59.01

7.62

2

70.36

57.97

12.39

3

66.57

64.73

1.84

4

71.76

60.95

10.81

Mean value

68.83

60.67

8.17

 

Table 2. Comparison of the relative area of the interstitial space (% of the total area) in the experimental and control groups

Таблица 2. Сравнение относительной площади (% от общей площади) межуточного пространства в опытной и контрольной группах

Eye

Experiment,%

Control, %

Reduction in the relative area of interstitial space in the experimental samples compared with control samples, %

1

10.96

16.02

5.06

2

13.83

17.89

4.06

3

10.97

17.32

6.35

4

8.96

14.24

5.28

Mean value

11.18

16.37

5.19

 

We observed an 8.2% increase in the packing density of collagen fibers and a 5.2% decrease of the interstitial space in response to scleral crosslinking with riboflavin/UVA.

Regularly alternating fibrils forming collagen fibers were seen on the electron microscopic images (Figure 4). Inside the fibrils, we observed a typical cross striation with a clear regularity. We identified no pathological changes in the scleral fibers in both groups.

 

Fig. 4. Collagen fibrils bunches’ transversal (a) and longitudinal (b) sections from experimental and control groups (magnification ×10,000)

 

We assessed the condition of sclerocytes and found that they maintained structural integrity without damages to the cell wall (Figure 5). Some sclerocytes had elongated cytoplasmic processes of irregular shape where the intact nucleus, organelles, and cytoplasm could be visualized. Quantitative analysis of electronograms showed that crosslinking with riboflavin/UVA increased the diameter of collagen fibrils by 12% on average (Table 3).

 

Fig. 5. Sclerocytes from experimental and control groups (magnification ×10,000)

 

Table 3. Comparison of the collagen fibrils mean diameter in the scleral samples from experimental eye and contralateral control eye

Таблица 3. Сравнение среднего диаметра коллагеновых фибрилл опытных и парных контрольных образцов склеры

Eye

Experimental sample (pixel)

Control sample (pixel)

1

177.09

152.95

2

186.00

168.33

3

192.86

175.05

Mean value

185.32 (112%)

165.44 (100%)

 

Discussion

We assessed the impact of crosslinking with riboflavin/UVA on the structure of the sclera using light and electron microscopy. We found no pathological changes in the sclera of the experimental samples after crosslinking compared with control samples. On the contrary, we observed a compaction of collagen fibers and an increase in the diameter of scleral fibrils. Our data are consistent with the results of other authors. Wollensak et al. observed only a few damaged sclerocytes after crosslinking without any pathological changes in scleral fibers, using electron microscopy. Scleral tissue was concluded to be highly resistant to harmful UV radiation [15]. Choi et al. detected a 27% increase in the diameter of collagen fibrils in the sclera after crosslinking [7]. Jung et al. observed a denser arrangement of collagen fibers after crosslinking using light microscopy.However, this study was limited to just one cadaver eye in which the density of fibers was estimated subjectively, without any morphometric analysis [8].

The results of our study confirm currently available data suggesting relatively high UV stability of the scleral tissue. Increased diameter of collagen fibrils and higher density of scleral fibers after crosslinking are associated with the formation of additional crosslinks pushing the collagen molecules away from each other [8, 12].

Conclusion

Scleral crosslinking with riboflavin/UVA increased the packing density of collagen fibers by 8.2%, reduced the interstitial space by 5.2%, and increased the diameter of collagen fibrils by 12%. Our data confirm the formation of additional crosslinks between the macromolecules of the sclera. Exposure to UV radiation in the presence of a photosensitizer does not induce pathological changes in the cells and fibers of the sclera. Therefore, this method is safe and could be used for the sclera.

×

About the authors

Mukharram M. Bikbov

Ufa Eye Research Institute

Author for correspondence.
Email: eye@anrb.ru

DMedSc, professor, director

Russian Federation, Ufa

Valentina K. Surkova

Ufa Eye Research Institute

Email: ufaeyenauka@mail.ru

DMedSc, professor, leading scientific researcher of the Department of the cornea and lens surgery

Russian Federation, Ufa

Emin L. Usubov

Ufa Eye Research Institute

Email: emines.us@inbox.ru

PhD, leading scientific researcher of the Department of the cornea and lens surgery

Russian Federation, Ufa

Nikolaj A. Nikitin

Ufa Eye Research Institute

Email: nic@ufanet.ru

PhD, leading scientific researcher of the Department of the cornea and lens surgery

Russian Federation, Ufa

Mikhail N. Astrelin

Ufa Eye Research Institute

Email: astrelin87@yandex.ru

scientific researcher of the Department of the cornea and lens surgery

Russian Federation, Ufa

References

  1. Бикбов М.М., Бикбова Г.М. Эктазии роговицы (патогенез, патоморфология, клиника, диагностика, лечение). – М.: Офтальмология, 2011. – 164 c., ил. [Bikbov MM, Bikbova GM. Jektazii rogovicy (patogenez, patomorfologija, klinika, diag nostika, lechenie). Moscow: Oftal’mologija; 2011. 164 p. (In Russ.)]
  2. Бикбов М.М., Бикбова Г.М., Суркова В.К., Зайнуллина Н.Б. Клинические результаты лечения кератоконуса методом трансэпителиального кросслинкинга роговичного коллагена // Офтальмология. – 2016. – Т. 13. – № 1. – С. 4–9. [Bikbov MM, Bikbova GM, Surkova VK, Zajnullina NB. Klinicheskie rezul’taty lechenija keratokonusa metodom transjepitelial’nogo krosslinkinga rogovichnogo kollagena. Oftal’mologija. 2016;13(1):4-9. (In Russ.)]
  3. Бикбов М.М., Суркова В.К., Усубов Э.Л., Астрелин М.Н. Кросс линкинг склеры с рибофлавином и ультрафиолетом А (UVA). Обзор литературы // Офтальмология. – 2015. – T. 12. – № 4. – С. 4–8. [Bikbov MM, Surkova VK, Usubov EL, Astrelin MN. Krosslinking sklery s riboflavinom i ul’trafioletom A (UVA). Obzor literatury. Oftal’mologija. 2015;12(4):4-8. (In Russ.)].
  4. Уикли Б. Электронная микроскопия для начинающих. Пер. с англ. – М: Мир, 1975. – 324 с. [Uikli B. Jelektronnaja mikroskopija dlja nachinajushhih. Moscow: Mir; 1975. 324 p. (In Russ.)]
  5. Bikbova G, Bikbov M. Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmologica. 2014;92(1):30-34. doi: 10.1111/aos.12235.
  6. Bullimore MA, Jones LA, Moeschberger ML, et al. A retrospective study of myopia progression in adult contact lens wearers. Invest Ophthalmol Vis Sci. 2002;43(7):2110-2113.
  7. Choi S, Lee S-C, Lee H-J, Cheong Y, et al. Structural response of human corneal and scleral tissues to collagen cross-linking treatment with riboflavin and ultraviolet A light. Lasers Med. Sci. 2013;28(5):1289-1296. doi: 10.1007/s10103-012-1237-6.
  8. Jung G-B, Lee H-J, Kim J-H, et al. Effect of cross-linking with riboflavin and ultraviolet A on the chemical bonds and ultrastructure of human sclera. J Biomed Opt. 2011;16(12):125004. doi: 10.1117/1.3662458.
  9. Liu T-X, Wang Z. Collagen crosslinking of porcine sclera using genipin. Acta Ophthalmol. 2013;91(4):253-257. doi: 10.1111/aos.12172.
  10. Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt. 2012;32(1):3-16. doi: 10.1111/j.1475-1313.2011.00884.x.
  11. Rada JAS, Shelton S, Norton TT. The sclera and myopia. Exp Eye Res. 2006;82(2):185-200. doi: 10.1016/j.exer.2005.08.009.
  12. Tanaka S, Eikenberry EF. Glycation induces expansion of the molecular packing of collagen. J Mol Biol. 1988;203(2):495-505. doi: 10.1016/0022-2836(88)90015-0.
  13. Wang M, Zhang F, Qian X, Zhao X. Regional Biomechanical properties of human sclera after cross-linking by riboflavin/ultraviolet A. J Refract Surg. 2012;28(10):723-728. doi: 10.3928/1081597X-20120921-08.
  14. Wollensak G, Iomdina E. Long-term biomechanical properties of rabbit sclera after collagen crosslinking using riboflavin and ultraviolet A (UVA). Acta Ophthalmol. 2009;87(2):193-198. doi: 10.1111/j.1755-3768.2008.01229.x.
  15. Wollensak G, Iomdina E, Dittert DD, et al. Cross-linking of scleral collagen in the rabbit using riboflavin and UVA. Acta Ophthalmol Scand. 2005;83(4):477-482. doi: 10.1111/j.1600-0420.2005.00447.x.
  16. Wollensak G, Spoerl E. Collagen crosslinking of human and porcine sclera. J Cataract Refract Surg. 2004;30(3):689-695. doi: 10.1016/j.jcrs.2003.11.032.
  17. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-627. doi: 10.1016/S0002-9394(02)02220-1.
  18. Zhang Y, Zou C, Liu L, et al. Effect of irradiation time on riboflavin-ultraviolet-A collagen crosslinking in rabbit sclera. J Cataract Refract Surg. 2013;39(8):1184-1189. doi: 10.1016/j.jcrs.2013.02.055.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Bikbov M.M., Surkova V.K., Usubov E.L., Nikitin N.A., Astrelin M.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies